Cargando…

Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study

BACKGROUND: Central line–associated bloodstream infections (CLABSIs) remain a critical and possibly fatal outcome of hospitalization. Use of central venous catheter (CVC) bundles can considerably reduce CLABSI rates in hospitalized patients. However, despite widespread adoption of these bundles in h...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitiriga, Vassiliki, Bakalis, John, Kampos, Elsa, Kanellopoulos, Petros, Saroglou, George, Tsakris, Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284713/
https://www.ncbi.nlm.nih.gov/pubmed/35841083
http://dx.doi.org/10.1186/s13756-022-01131-w
_version_ 1784747624387051520
author Pitiriga, Vassiliki
Bakalis, John
Kampos, Elsa
Kanellopoulos, Petros
Saroglou, George
Tsakris, Athanasios
author_facet Pitiriga, Vassiliki
Bakalis, John
Kampos, Elsa
Kanellopoulos, Petros
Saroglou, George
Tsakris, Athanasios
author_sort Pitiriga, Vassiliki
collection PubMed
description BACKGROUND: Central line–associated bloodstream infections (CLABSIs) remain a critical and possibly fatal outcome of hospitalization. Use of central venous catheter (CVC) bundles can considerably reduce CLABSI rates in hospitalized patients. However, despite widespread adoption of these bundles in hospitals worldwide, CLABSIs still remain prevalent. The aim of the present study was to determine whether longer duration of CVCs placement is related to CLABSIs in hospitalized adults, despite the implementation of preventive bundles. Also to analyse CLABSI pathogens distribution and antimicrobial resistance profiles in different time intervals of catheterization. METHODS: A retrospective study was performed among hospitalized patients who had a CVC inserted during a 24-month period (May 2017–May 2019) and developed CLABSIs. To evaluate the association between CVC placement duration and CLABSI events, we categorized events into three groups, each representing a 10-day time interval. RESULTS: A total of 59 CLABSI cases were identified among 9774 catheter/days. The CLABSI incidence rate per 1000 catheter/days was 4.80 for duration of catheterization up to 10 days, 5.92 for duration of 11–20 days, and 8.64 for duration > 20 days(p = 0.007). The CLABSI incidence rate per 1000 catheter/days due to multidrug-resistant organisms (MDROs) among the three groups was 2.62 for catheter duration of up to 10 days, 3.83 for 11–20 days, and 3.46 for > 20 days (p = 0.14). Among CLABSIs, the most common microorganism identified was multidrug-resistant Acinetobacter baumannii, which accounted for 27.1% of the cases. There was no significant difference in the type of CLABSI pathogens isolated among the 3 groups. CONCLUSIONS: Our findings suggest that duration of CVC placement remains an important risk factor for CLABSIs in hospitalized patients, even after the adoption of prevention bundles. The high prevalence of MDROs in our setting reflects the local epidemiology, highlighting a significant threat of urgent public health concern.
format Online
Article
Text
id pubmed-9284713
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92847132022-07-16 Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study Pitiriga, Vassiliki Bakalis, John Kampos, Elsa Kanellopoulos, Petros Saroglou, George Tsakris, Athanasios Antimicrob Resist Infect Control Research BACKGROUND: Central line–associated bloodstream infections (CLABSIs) remain a critical and possibly fatal outcome of hospitalization. Use of central venous catheter (CVC) bundles can considerably reduce CLABSI rates in hospitalized patients. However, despite widespread adoption of these bundles in hospitals worldwide, CLABSIs still remain prevalent. The aim of the present study was to determine whether longer duration of CVCs placement is related to CLABSIs in hospitalized adults, despite the implementation of preventive bundles. Also to analyse CLABSI pathogens distribution and antimicrobial resistance profiles in different time intervals of catheterization. METHODS: A retrospective study was performed among hospitalized patients who had a CVC inserted during a 24-month period (May 2017–May 2019) and developed CLABSIs. To evaluate the association between CVC placement duration and CLABSI events, we categorized events into three groups, each representing a 10-day time interval. RESULTS: A total of 59 CLABSI cases were identified among 9774 catheter/days. The CLABSI incidence rate per 1000 catheter/days was 4.80 for duration of catheterization up to 10 days, 5.92 for duration of 11–20 days, and 8.64 for duration > 20 days(p = 0.007). The CLABSI incidence rate per 1000 catheter/days due to multidrug-resistant organisms (MDROs) among the three groups was 2.62 for catheter duration of up to 10 days, 3.83 for 11–20 days, and 3.46 for > 20 days (p = 0.14). Among CLABSIs, the most common microorganism identified was multidrug-resistant Acinetobacter baumannii, which accounted for 27.1% of the cases. There was no significant difference in the type of CLABSI pathogens isolated among the 3 groups. CONCLUSIONS: Our findings suggest that duration of CVC placement remains an important risk factor for CLABSIs in hospitalized patients, even after the adoption of prevention bundles. The high prevalence of MDROs in our setting reflects the local epidemiology, highlighting a significant threat of urgent public health concern. BioMed Central 2022-07-15 /pmc/articles/PMC9284713/ /pubmed/35841083 http://dx.doi.org/10.1186/s13756-022-01131-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pitiriga, Vassiliki
Bakalis, John
Kampos, Elsa
Kanellopoulos, Petros
Saroglou, George
Tsakris, Athanasios
Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study
title Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study
title_full Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study
title_fullStr Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study
title_full_unstemmed Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study
title_short Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study
title_sort duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284713/
https://www.ncbi.nlm.nih.gov/pubmed/35841083
http://dx.doi.org/10.1186/s13756-022-01131-w
work_keys_str_mv AT pitirigavassiliki durationofcentralvenouscatheterplacementandcentrallineassociatedbloodstreaminfectionsaftertheadoptionofpreventionbundlesatwoyearretrospectivestudy
AT bakalisjohn durationofcentralvenouscatheterplacementandcentrallineassociatedbloodstreaminfectionsaftertheadoptionofpreventionbundlesatwoyearretrospectivestudy
AT kamposelsa durationofcentralvenouscatheterplacementandcentrallineassociatedbloodstreaminfectionsaftertheadoptionofpreventionbundlesatwoyearretrospectivestudy
AT kanellopoulospetros durationofcentralvenouscatheterplacementandcentrallineassociatedbloodstreaminfectionsaftertheadoptionofpreventionbundlesatwoyearretrospectivestudy
AT saroglougeorge durationofcentralvenouscatheterplacementandcentrallineassociatedbloodstreaminfectionsaftertheadoptionofpreventionbundlesatwoyearretrospectivestudy
AT tsakrisathanasios durationofcentralvenouscatheterplacementandcentrallineassociatedbloodstreaminfectionsaftertheadoptionofpreventionbundlesatwoyearretrospectivestudy